Critical role for Streptococcus suis cell wall modifications and suilysin in resistance to complement-dependent killing by dendritic cells

Journal of Infectious Diseases

Volumn 204, Issue 6, 2011, Pages 919-929

  Lecours, Marie Pier ^a   Gottschalk, Marcelo ^a   Houde, Mathieu ^a   Lemire, Paul ^a   Fittipaldi, Nahuel ^a,b   Segura, Mariela ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; CXCL1 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HEMOLYSIN; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; LIPOTEICHOIC ACID; MONOCYTE CHEMOTACTIC PROTEIN 1; PEPTIDOGLYCAN; SUILYSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ALANYLATION; ANIMAL CELL; ARTICLE; BACTERIAL CELL WALL; BIOTRANSFORMATION; CELL ACTIVATION; CELL MATURATION; COMPLEMENT DEPENDENT CYTOTOXICITY; COMPLEMENT DEPOSITION; CONTROLLED STUDY; CYTOKINE RELEASE; DEACETYLATION; DENDRITIC CELL; FEMALE; INTERNALIZATION; MOUSE; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; STREPTOCOCCUS SUIS;

ANIMALS; BACTERIAL CAPSULES; BACTERIOLYSIS; CELL WALL; COMPLEMENT SYSTEM PROTEINS; CYTOKINES; DENDRITIC CELLS; FEMALE; HEMOLYSIN PROTEINS; IMMUNE EVASION; LIPOPOLYSACCHARIDES; MICE; PEPTIDOGLYCAN; PHAGOCYTOSIS; STREPTOCOCCUS SUIS; TEICHOIC ACIDS;

EID: 80052010564     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir415     Document Type: Article

References (50)

1. Gottschalk M, Xu J, Calzas C, Segura M. Streptococcus suis: a new emerging or an old neglected zoonotic pathogen? Future Microbiol 2010; 5:371-91.
2. Gottschalk M, Segura M. The pathogenesis of the meningitis caused by Streptococcus suis: the unresolved questions. Vet Microbiol 2000; 76: 259-72.
3. del Campo Sepulveda EM, Altman E, Kobisch M, D'Allaire S, Gottschalk M. Detection of antibodies against Streptococcus suis capsular type 2 using a purified capsular polysaccharide antigen-based indirect ELISA. Vet Microbiol 1996; 52:113-25. (Pubitemid 26352880)
4. Segura M, Gottschalk M, Olivier M. Encapsulated Streptococcus suis inhibits activation of signaling pathways involved in phagocytosis. Infect Immun 2004; 72:5322-30.
5. Chabot-Roy G, Willson P, Segura M, Lacouture S, Gottschalk M. Phagocytosis and killing of Streptococcus suis by porcine neutrophils. Microb Pathog 2006; 41:21-32. (Pubitemid 44088586)
6. Van Calsteren MR, Gagnon F, Lacouture S, Fittipaldi N, Gottschalk M. Structure determination of Streptococcus suis serotype 2 capsular polysaccharide. Biochem Cell Biol 2010; 88:513-25.
7. Baums CG, Valentin-Weigand P. Surface-associated and secreted factors of Streptococcus suis in epidemiology, pathogenesis and vaccine development. Anim Health Res Rev 2009; 10:65-83.
8. Segura M, Gottschalk M. Extracellular virulence factors of streptococci associated with animal diseases. Front Biosci 2004; 9:1157-88. (Pubitemid 39066205)
9. Fittipaldi N, Sekizaki T, Takamatsu D, et al. D-alanylation of lipoteichoic acid contributes to the virulence of Streptococcus suis. Infect Immun 2008; 76:3587-94.
10. Fittipaldi N, Sekizaki T, Takamatsu D, et al. Significant contribution of the pgdA gene to the virulence of Streptococcus suis. Mol Microbiol 2008; 70:1120-35.
11. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991; 9:271-96.
12. Dominguez-Punaro MC, Segura M, Plante MM, Lacouture S, Rivest S, Gottschalk M. Streptococcus suis serotype 2, an important swine and human pathogen, induces strong systemic and cerebral inflammatory responses in a mouse model of infection. J Immunol 2007; 179: 1842-54.
13. Kobisch M, Gottschalk M, Morvan P, Cariolet G, Bénévent G, Joly JP. Experimental infection of SPF piglets with Streptococcus suis serotype 2. J Rech Porcine Fr 1995; 27:97-102.
14. Segura M, Vanier G, Al-Numani D, Lacouture S, Olivier M, Gottschalk M. Proinflammatory cytokine and chemokine modulation by Streptococcus suis in a whole-blood culture system. FEMS Immunol Med Microbiol 2006; 47:92-106.
15. Lun S, Perez-Casal J, Connor W, Wilson PJ. Role of suilysin in pathogenesis of Streptococcus suis capsular serotype 2. Microb Pathog 2003; 34:27-37. (Pubitemid 36287212)
16. Slater JD, Allen AG, May JP, Bolitho S, Lindsay H, Maskell DJ. Mutagenesis of Streptococcus equi and Streptococcus suis by transposon Tn917. Vet Microbiol 2003; 93:197-206. (Pubitemid 36412119)
17. Takamatsu D, Osaki M, Sekizaki T. Thermosensitive suicide vectors for gene replacement in Streptococcus suis. Plasmid 2001; 46:140-8.
18. Vadeboncoeur N, Segura M, Al-Numani D, Vanier G, Gottschalk M. Pro-inflammatory cytokine and chemokine release by human brain microvascular endothelial cells stimulated by Streptococcus suis serotype 2.FEMS Immunol Med Microbiol 2003; 35:49-58.
19. Vanier G, Segura M, Lecours MP, Grenier D, Gottschalk M. Porcine brain microvascular endothelial cell-derived interleukin-8 is first induced and then degraded by Streptococcus suis. Microb Pathog 2009; 46:135-43.
20. Holden MT, Hauser H, Sanders M, et al. Rapid evolution of virulence and drug resistance in the emerging zoonotic pathogen Streptococcus suis. PLoS One 2009; 4:e6072.
21. Warrens AN, Jones MD, Lechler RI. Splicing by overlap extension by PCR using asymmetric amplification: an improved technique for the generation of hybrid proteins of immunological interest. Gene 1997; 186:29-35. (Pubitemid 27084826)
22. Takamatsu D, Osaki M, Sekizaki T. Construction and characterization of Streptococcus suis-Escherichia coli shuttle cloning vectors. Plasmid 2001; 45:101-13. (Pubitemid 32221956)
23. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning, a laboratory manual. New York, NY: Cold Spring Harbor Laboratory Press, 1989.
24. Jacques M, Gottschalk M, Foiry B, Higgins R. Ultrastructural study of surface components of Streptococcus suis. J Bacteriol 1990; 172:2833-8.
25. Segura M, Su Z, Piccirillo C, Stevenson MM. Impairment of dendritic cell function by excretory-secretory products: a potential mechanism for nematode-induced immunosuppression. Eur J Immunol 2007; 37: 1887-904. (Pubitemid 47065127)
26. Ing R, Segura M, Thawani N, Tam M, Stevenson MM. Interaction of mouse dendritic cells and malaria-infected erythrocytes: uptake, maturation, and antigen presentation. J Immunol 2006; 176:441-50. (Pubitemid 43023290)
27. Vanier G, Segura M, Friedl P, Lacouture S, Gottschalk M. Invasion of porcine brain microvascular endothelial cells by Streptococcus suis serotype 2. Infect Immun 2004; 72:1441-9.
28. Alcantara RB, Preheim LC, Gentry-Nielsen MJ. Pneumolysin-induced complement depletion during experimental pneumococcal bacteremia. Infect Immun 2001; 69:3569-75.
29. Severi E, Hood DW, Thomas GH. Sialic acid utilization by bacterial pathogens. Microbiology 2007; 153:2817-22.
30. Neuhaus FC, Baddiley J. A continuum of anionic charge: structures and functions of D-alanyl-alanyl-Teichoic acids in gram-positive bacteria. Microbiol Mol Biol Rev 2003; 67:686-723. (Pubitemid 37549774)
31. Loos M, Clas F, Fischer W. Interaction of purified lipoteichoic acid with the classical complement pathway. Infect Immun 1986; 53:595-9.
32. Cox KH, Ruiz-Bustos E, Courtney HS, et al. Inactivation of DltA modulates virulence factor expression in Streptococcus pyogenes. PLoS One 2009; 4:e5366.
33. Vollmer W. Structural variation in the glycan strands of bacterial peptidoglycan. FEMS Microbiol Rev 2008; 32:287-306. (Pubitemid 351257811)
34. Franklin K, Clarke AJ. Overexpression and characterization of the chromosomal aminoglycoside 2′-N-acetyltransferase of Providencia stuartii. Antimicrob Agents Chemother 2001; 45:2238-44. (Pubitemid 32664462)
35. Dillard JP, Hackett KT. Mutations affecting peptidoglycan acetylation in Neisseria gonorrhoeae and Neisseria meningitidis. Infect Immun 2005; 73:5697-705. (Pubitemid 41193005)
36. Oppmann B, Lesley R, Blom B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000; 13:715-25.
37. de Jong EC, Smits HH, Kapsenberg ML. Dendritic cell-mediated T cell polarization. Springer Semin Immunopathol 2005; 26:289-307.
38. Graveline R, Segura M, Radzioch D, Gottschalk M. TLR2-dependent recognition of Streptococcus suis is modulated by the presence of capsular polysaccharide which modifies macrophage responsiveness. Int Immunol 2007; 19:375-89. (Pubitemid 46523386)
39. Tanabe S, Gottschalk M, Grenier D. Hemoglobin and Streptococcus suis CW act in synergy to potentiate the inflammatory response of monocyte-derived macrophages. Innate Immun 2008; 14:357-63.
40. Chan KG, Mayer M, Davis EM, Halperin SA, Lin TJ, Lee S.F. Role of D-alanylation of Streptococcus gordonii lipoteichoic acid in innate and adaptive immunity. Infect Immun 2007; 75:3033-42.
41. Durand SH, Flacher V, Romeas A, et al. Lipoteichoic acid increases TLR and functional chemokine expression while reducing dentin formation in in vitro differentiated human odontoblasts. J Immunol 2006; 176:2880-7.
42. Proost P, Vynckier AK, Mahieu F, et al. Microbial Toll-loike receptor ligands differentially regulate CXCL10/IP-10 expression in fibroblasts and mononuclear leukocytes in synergy with IFN-gamma and provide a mechanism for enhanced synovial chemokine levels in septic arthritis. Eur J Immunol 2003; 33:3146-53.
43. Bernatoniene J, Zhang Q, Dogan S, Mitchell TJ, Paton JC, Finn A. Induction of CC and CXC chemokines in human antigen-presenting dendritic cells by the pneumococcal proteins pneumolysin and CbpA, and the role played by Toll-like receptor 4, NF-kappaB, and mitogen-activated protein kinases. J Infect Dis 2008; 198:1823-33.
44. Segura M, Stankova J, Gottschalk M. Heat-killed Streptococcus suis capsular type 2 strains stimulate tumor necrosis factor alpha and interleukin-6 production by murine macrophages. Infect Immun 1999; 67:4646-54.
45. Segura M., Vadeboncoeur N., Gottschalk M. CD14-dependent and -independent cytokine and chemokine production by human THP-1 monocytes stimulated by Streptococcus suis capsular type 2. Clin Exp Immunol 2002; 127:243-54. (Pubitemid 34233929)
46. Sutterwala F.S., Noel G.J., Clynes R., Mosser D.M. Selective suppression of interleukin-12 induction after macrophage receptor ligation. J Exp Med 1997; 185:1977-85.
47. Waggoner S.N., Cruise M.W., Kassel R., Hahn Y.S. gC1q receptor ligation selectively down-regulates human IL-12 production through activation of the phosphoinositide 3-kinase pathway. J Immunol 2005; 175:4706-14.
48. Luo X., Liu L., Tang N., et al. Inhibition of monocyte-derived dendritic cell differentiation and interleukin-12 production by complement iC3b via a mitogen-activated protein kinase signalling pathway. Exp Dermatol 2005; 14:303-10. (Pubitemid 40485459)
49. Yoshida Y., Kang K., Berger M., et al. Monocyte induction of IL-10 and down-regulation of IL-12 by iC3b deposited in ultraviolet-exposed human skin. J Immunol 1998; 161:5873-9.
50. Thibodeau J., Bourgeois-Daigneault M.C., Huppe G., et al. Interleukin-10-induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes. Eur J Immunol 2008; 38:1225-30.